5-hydroxytryptophan in combination with clomipramine in "therapy-resistant" depressions.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D003863:Depression / Q000188:drug therapy*; D003984:Dibenzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012701:Serotonin / Q000378:metabolism
D000928:Antidepressive Agents; D003984:Dibenzazepines; D011437:Propylamines; D012701:Serotonin; D006916:5-Hydroxytryptophan; D002262:Carboxy-Lyases